Clinical Trials Browser

Unknown × Antibodies, Monoclonal × Lymphoid × Clear all

NCT05073250 2023-05-12

IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT00515892 2007-08-14

NHL

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin